MDT

96.46

-0.47%↓

A

146.44

-1.03%↓

VEEV

228.35

-1.98%↓

HQY

84.03

-0.27%↓

PHR.US

16.54

-3.44%↓

MDT

96.46

-0.47%↓

A

146.44

-1.03%↓

VEEV

228.35

-1.98%↓

HQY

84.03

-0.27%↓

PHR.US

16.54

-3.44%↓

MDT

96.46

-0.47%↓

A

146.44

-1.03%↓

VEEV

228.35

-1.98%↓

HQY

84.03

-0.27%↓

PHR.US

16.54

-3.44%↓

MDT

96.46

-0.47%↓

A

146.44

-1.03%↓

VEEV

228.35

-1.98%↓

HQY

84.03

-0.27%↓

PHR.US

16.54

-3.44%↓

MDT

96.46

-0.47%↓

A

146.44

-1.03%↓

VEEV

228.35

-1.98%↓

HQY

84.03

-0.27%↓

PHR.US

16.54

-3.44%↓

Search

Guardant Health Inc

Fechado

SetorSaúde

106.87 -0.61

Visão Geral

Variação de preço das ações

24h

Atual

Mín

103.32

Máximo

108.25

Indicadores-chave

By Trading Economics

Rendimento

7.2M

-93M

Vendas

33M

265M

Margem de lucro

-34.965

Funcionários

1,999

EBITDA

6.6M

-82M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+15.92% upside

Dividendos

By Dow Jones

Próximos Ganhos

19 de fev. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

5B

14B

Abertura anterior

107.48

Fecho anterior

106.87

Sentimento de Notícias

By Acuity

50%

50%

183 / 361 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Very Strong Bearish Evidence

Guardant Health Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

13 de jan. de 2026, 19:05 UTC

Grandes Movimentos do Mercado

Travere Therapeutics Shares Fall After FDA Extends Filspari Review

13 de jan. de 2026, 23:41 UTC

Conversa de Mercado

Nikkei May Rise on Japan Election Hopes -- Market Talk

13 de jan. de 2026, 23:41 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

13 de jan. de 2026, 23:33 UTC

Conversa de Mercado

Gold Edges Higher, Supported by Ongoing Geopolitical Tensions -- Market Talk

13 de jan. de 2026, 23:13 UTC

Aquisições, Fusões, Aquisições de Empresas

JD Logistics Plans to Withdraw Listing Status of Deppon Logistics From Shanghai Stock Exchange

13 de jan. de 2026, 23:10 UTC

Aquisições, Fusões, Aquisições de Empresas

JD Logistics Makes Cash Offer to Buy Deppon Logistics Shares It Doesn't Already Own

13 de jan. de 2026, 23:03 UTC

Conversa de Mercado

Woodside's Sales Revenue Likely Fell 13% in 4Q -- Market Talk

13 de jan. de 2026, 21:50 UTC

Aquisições, Fusões, Aquisições de Empresas

Netflix Preparing to Make Warner Bid All-Cash -- WSJ

13 de jan. de 2026, 21:50 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Basic Materials Roundup: Market Talk

13 de jan. de 2026, 21:20 UTC

Aquisições, Fusões, Aquisições de Empresas

Versant Media: Katz Will Continue to Lead Day-To-Day Ops of FTN

13 de jan. de 2026, 21:20 UTC

Aquisições, Fusões, Aquisições de Empresas

Versant Media: Transaction Strengthens Distribution Footprint and Expands Free-To-Watch Portfolio >VSNT

13 de jan. de 2026, 21:20 UTC

Aquisições, Fusões, Aquisições de Empresas

Versant Media: Jonathan Katz, FTN's Founder, Has Joined VERSANT, Reporting to David Pietrycha >VSNT

13 de jan. de 2026, 21:15 UTC

Aquisições, Fusões, Aquisições de Empresas

VERSANT Completes Acquisition Of Free TV Networks >VSNT

13 de jan. de 2026, 21:08 UTC

Aquisições, Fusões, Aquisições de Empresas

Array Digital Infrastructure Declares Special Dividend of $10.25 >AD

13 de jan. de 2026, 20:39 UTC

Conversa de Mercado

Silver Settles at Another New High -- Market Talk

13 de jan. de 2026, 20:21 UTC

Conversa de Mercado

Oil Futures Extend Rally On Rising Iran Tensions -- Market Talk

13 de jan. de 2026, 20:17 UTC

Conversa de Mercado

U.S. Natural Gas Edges Up on Coming Weather -- Market Talk

13 de jan. de 2026, 19:08 UTC

Aquisições, Fusões, Aquisições de Empresas

Super Micro Computer Is an AI Winner. Sell the Stock Anyway, Goldman Sachs Says. -- Barrons.com

13 de jan. de 2026, 19:03 UTC

Ganhos

Double-Digit Earnings Growth Could Continue. It Still Might Not Satisfy Investors. -- Barrons.com

13 de jan. de 2026, 18:50 UTC

Ganhos

JPMorgan's Unusual Quarter Weighs on Shares. How Apple Plays a Role. -- Barrons.com

13 de jan. de 2026, 17:54 UTC

Conversa de Mercado

UnitedHealth Reaffirms 2025 Guidance After Senate Report -- Market Talk

13 de jan. de 2026, 17:50 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Global Equities Roundup: Market Talk

13 de jan. de 2026, 17:50 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Netflix Will Be a Winner No Matter How Warner Saga Ends -- Market Talk

13 de jan. de 2026, 17:49 UTC

Conversa de Mercado

Analysts Call For Potential Record Ethanol Output -- Market Talk

13 de jan. de 2026, 17:38 UTC

Conversa de Mercado

Merck CEO Sees $5B Market for Cidara's Flu Antiviral -- Market Talk

13 de jan. de 2026, 17:20 UTC

Conversa de Mercado

Financial Services Roundup: Market Talk

13 de jan. de 2026, 17:20 UTC

Conversa de Mercado

Health Care Roundup: Market Talk

13 de jan. de 2026, 17:20 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Basic Materials Roundup: Market Talk

13 de jan. de 2026, 17:19 UTC

Conversa de Mercado

Credit Cards Present Opportunity, Potential Obstacle for JPMorgan -- Market Talk

13 de jan. de 2026, 17:15 UTC

Conversa de Mercado

Merck CEO Sees Eventual Growth After Keytruda Exclusivity Expires -- Market Talk

Comparação entre Pares

Variação de preço

Guardant Health Inc Previsão

Preço-alvo

By TipRanks

15.92% parte superior

Previsão para 12 meses

Média 124.69 USD  15.92%

Máximo 155 USD

Mínimo 105 USD

Com base em 19 analistas de Wall Street que oferecem metas de preço de 12 meses para Guardant Health Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

19 ratings

18

Comprar

1

Manter

0

Vender

Pontuação Técnica

By Trading Central

38.86 / 47.41Suporte e Resistência

Curto Prazo

Very Strong Bearish Evidence

Médio Prazo

Bearish Evidence

Longo Prazo

Bullish Evidence

Sentimento

By Acuity

183 / 361 Ranking em Saúde

Sentimento de Notícias

Neutral

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Guardant Health Inc

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research; and with ConcertAI to form first data-as-a-service that integrates clinical and tumor profiling data to accelerate cancer therapy research and development. The company was incorporated in 2011 and is headquartered in Palo Alto, California.
help-icon Live chat